![Assay: Irreversible inhibition of rat brain cytosolic MAGL assessed as [3H] - EMBL-EBI](https://cedclinic.com/wp-content/uploads/2026/06/ced-pexels-4226264-1-150x150.jpg "Assay: Irreversible inhibition of rat brain cytosolic MAGL assessed as [3H] - EMBL-EBI 17")
Medical Cannabis Use Rises with Age Among Cannabis Users, but Stays Constant Across the Full Adult Population
Medical use was associated with higher past 30-day frequency across age, indicating that it acts as a consistent risk factor for daily or near-daily use.
Cannabis Use Among Individuals Treated with Medication for Opioid Use Disorder: Correlates, Patterns, and Motivations for Use.
Cannabis use is prevalent among patients receiving medication for opioid use disorder (MOUD). However, little is known about factors associated with frequent...
Endocannabinoid System Trauma Treatment and PTSD Research
Clinical Takeaway Cannabis use does not significantly impair outcomes of evidence-based trauma-focused treatments for people with co-occurring PTSD and substance use disorders. Trauma-focused therapy remains an effective approach for this population…
Combined Impact of Cannabinoids and Cocaine on Outcomes of Trauma Patients.
In recent years, the use of polypharmacy has surged. There is a gap in knowledge regarding the impact of pre-injury use of polypharmacy on outcomes. The purp...
Endocannabinoid System Research and Clinical Psychosis Care
Clinical Takeaway Clinical Takeaway People experiencing first-episode psychosis have measurable rates of criminal legal involvement that can be identified at baseline and tracked over treatment. Understanding which clinical and demographic factors…
Medical cannabis cuts prescription drug use by 85%, German patient survey finds – leafie
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolypharmacyDrug InteractionsPatient…
A Major International Cannabis Study Is Being Planned—Here Is What Researchers Intend to Find Out
Our approach will be largely data-driven, focused on untangling the effects of cannabis on mental health, either good or bad.
Cannabis Europa returns to London with patient issues on the agenda – leafie
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic IndustryPatient AccessMedical…
Ireland Moves Forward With Review of Medical Cannabis Programme
✦ New CED Clinical Relevance #76Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyMedical CannabisEpilepsyEuropean…
First year of Dutch cannabis pilot project a success | StratCann
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyInternational ResearchRegulatory…